- Home
- Publications
- Publication Search
- Publication Details
Title
Biosimilars: what clinicians should know
Authors
Keywords
-
Journal
BLOOD
Volume 120, Issue 26, Pages 5111-5117
Publisher
American Society of Hematology
Online
2012-10-24
DOI
10.1182/blood-2012-04-425744
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Subsequent entry biologics/biosimilars: a viewpoint from Canada
- (2012) Anthony S. Russell et al. CLINICAL RHEUMATOLOGY
- Biopharmaceuticals and biosimilars in psoriasis: What the dermatologist needs to know
- (2012) Bruce E. Strober et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Safety, immunogenicity and efficacy of subcutaneous biosimilar epoetin-α (HX575) in non-dialysis patients with renal anemia: a multi-center, randomized, double-blind study
- (2011) Marianne Haag-Weber et al. CLINICAL NEPHROLOGY
- Effective pharmaceutical regulation needs alignment with doctors
- (2011) Hans C. Ebbers et al. DRUG DISCOVERY TODAY
- The regulatory framework of biosimilars in the European Union
- (2011) Paola Minghetti et al. DRUG DISCOVERY TODAY
- Biosimilars of Biological Drug Therapies
- (2011) George Dranitsaris et al. DRUGS
- Key concepts and critical issues on epoetin and filgrastim biosimilars. A position paper from the Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation
- (2011) G. Barosi et al. HAEMATOLOGICA
- Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Association
- (2011) B. E. Shaw et al. HAEMATOLOGICA
- Acceptable changes in quality attributes of glycosylated biopharmaceuticals
- (2011) Martin Schiestl et al. NATURE BIOTECHNOLOGY
- Biosimilars—why terminology matters
- (2011) Martina Weise et al. NATURE BIOTECHNOLOGY
- Tungsten-Induced Denaturation and Aggregation of Epoetin Alfa During Primary Packaging as a Cause of Immunogenicity
- (2011) Andreas Seidl et al. PHARMACEUTICAL RESEARCH
- Biosimilar epoetins and other “follow-on” biologics: Update on the European experiences
- (2010) Wolfgang Jelkmann AMERICAN JOURNAL OF HEMATOLOGY
- Biosimilars: controversies as illustrated by rhGH
- (2010) Paul J. Declerck et al. CURRENT MEDICAL RESEARCH AND OPINION
- Biosimilar agents in oncology/haematology: from approval to practice
- (2010) Dietger Niederwieser et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Biosimilars and Regulatory Authorities
- (2010) Paola Minghetti et al. NEPHRON CLINICAL PRACTICE
- Quality of Original and Biosimilar Epoetin Products
- (2010) Vera Brinks et al. PHARMACEUTICAL RESEARCH
- Toward biosimilar monoclonal antibodies
- (2008) Christian K Schneider et al. NATURE BIOTECHNOLOGY
- Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council
- (2008) A. Covic et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Epoetin-associated pure red cell aplasia: past, present, and future considerations
- (2008) June M. McKoy et al. TRANSFUSION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started